Jpmorgan Chase & CO Glaukos Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GKOS
# of Institutions
310Shares Held
46.8MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$716 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$249 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$244 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$212 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.25B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...